A detailed history of Nano Dimension, Inc. transactions in Icosavax, Inc. stock. As of the latest transaction made, Nano Dimension, Inc. holds 1,361,658 shares of ICVX stock, worth $0. This represents 17.45% of its overall portfolio holdings.

Number of Shares
1,361,658
Previous 1,735,914 21.56%
Holding current value
$0
Previous $9.95 Million 56.74%
% of portfolio
17.45%
Previous 32.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$3.09 - $9.21 $1.16 Million - $3.45 Million
-374,256 Reduced 21.56%
1,361,658 $4.3 Million
Q2 2022

Jul 28, 2022

SELL
$5.7 - $10.33 $5.46 Million - $9.89 Million
-957,858 Reduced 35.56%
1,735,914 $9.95 Million
Q1 2022

May 11, 2022

SELL
$4.41 - $22.5 $247,939 - $1.26 Million
-56,222 Reduced 2.04%
2,693,772 $19 Million
Q4 2021

Feb 23, 2022

BUY
$21.07 - $34.98 $57.9 Million - $96.2 Million
2,749,994 New
2,749,994 $62.9 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Nano Dimension, Inc. Portfolio

Follow Nano Dimension, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nano Dimension, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nano Dimension, Inc. with notifications on news.